BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1592346)

  • 1. Effect of simvastatin, ursodeoxycholic acid and simvastatin plus ursodeoxycholic acid on biliary lipid secretion and cholic acid kinetics in nonfamilial hypercholesterolemia.
    Mazzella G; Parini P; Festi D; Bazzoli F; Aldini R; Roda A; Tonelli D; Cipolla A; Salzetta A; Roda E
    Hepatology; 1992 Jun; 15(6):1072-8. PubMed ID: 1592346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in biliary lipid secretion and cholic acid kinetics induced by diet, diet plus simvastatin and diet plus ursodeoxycholic acid in obese subjects.
    Mazzella G; Cipolla A; Villanova N; Polimeni C; Sipahi A; Parini P; Fusaroli P; Festi D; Roda E
    Ital J Gastroenterol; 1995; 27(8):441-5. PubMed ID: 8775472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of long term simvastatin administration as an adjunct to ursodeoxycholic acid: evidence for a synergistic effect on biliary bile acid composition but not on serum lipids in humans.
    Lanzarotto F; Panarotto B; Sorbara R; Panteghini M; Pagani F; Sosta S; Lanzini A
    Gut; 1999 Apr; 44(4):552-6. PubMed ID: 10075964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin, a competitive inhibitor of HMG-CoA reductase, lowers cholesterol saturation index of gallbladder bile.
    Duane WC; Hunninghake DB; Freeman ML; Pooler PA; Schlasner LA; Gebhard RL
    Hepatology; 1988; 8(5):1147-50. PubMed ID: 3047037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis.
    Nilsell K; Angelin B; Leijd B; Einarsson K
    Gastroenterology; 1983 Dec; 85(6):1248-56. PubMed ID: 6628924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursodeoxycholic acid treatment in humans: effects on plasma and biliary lipid metabolism with special reference to very low density lipoprotein triglyceride and bile acid kinetics.
    Angelin B; Nilsell K; Einarsson K
    Eur J Clin Invest; 1986 Apr; 16(2):169-77. PubMed ID: 3089812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combination therapy with simvastatin and ursodeoxycholic acid is more effective for cholesterol gallstone dissolution than is ursodeoxycholic acid monotherapy.
    Tazuma S; Kajiyama G; Mizuno T; Yamashita G; Miura H; Kajihara T; Hattori Y; Miyake H; Nishioka T; Hyogo H; Sunami Y; Yasumiba S; Ochi H; Matsumoto T; Abe A; Adachi K; Omata F; Ueno F; Sugata F; Ohguri S; Shibata H; Kokubu S
    J Clin Gastroenterol; 1998 Jun; 26(4):287-91. PubMed ID: 9649013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lovastatin added to ursodeoxycholic acid further reduces biliary cholesterol saturation.
    Logan GM; Duane WC
    Gastroenterology; 1990 Jun; 98(6):1572-6. PubMed ID: 2338194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of simvastatin and cholestyramine on bile lipid composition and gall bladder motility in patients with hypercholesterolaemia.
    Smit JW; Van Erpecum KJ; Portincasa P; Renooij W; Erkelens DW; Van Berge-Henegouwen GP
    Gut; 1995 Nov; 37(5):654-9. PubMed ID: 8549941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of chenodeoxycholic and ursodeoxycholic acids in obese patients. Effects on biliary lipid metabolism during weight maintenance and weight reduction.
    Mazzella G; Bazzoli F; Festi D; Ronchi M; Aldini R; Roda A; Grigolo B; Simoni P; Villanova N; Roda E
    Gastroenterology; 1991 Aug; 101(2):490-6. PubMed ID: 2065925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ursodeoxycholic acid administration on biliary lipid secretion in primary biliary cirrhosis.
    Roda E; Mazzella G; Bazzoli F; Villanova N; Minutello A; Simoni P; Ronchi M; Poggi C; Festi D; Aldini R
    Dig Dis Sci; 1989 Dec; 34(12 Suppl):52S-58S. PubMed ID: 2598768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
    Thistle JL; Larusso NF; Hofmann AF; Turcotte J; Carlson GL; Ott BJ
    Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7 alpha-hydroxylation rates in vivo.
    Bertolotti M; Abate N; Loria P; Dilengite M; Carubbi F; Pinetti A; Digrisolo A; Carulli N
    Hepatology; 1991 Nov; 14(5):830-7. PubMed ID: 1937389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol metabolism and serum and biliary noncholesterol sterols in gallstone patients during simvastatin and ursodeoxycholic acid treatments.
    Miettinen TE; Kiviluoto T; Taavitsainen M; Vuoristo M; Miettinen TA
    Hepatology; 1998 Mar; 27(3):649-55. PubMed ID: 9500689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term effects of simvastatin on bile acid synthesis and bile lipid secretion in human subjects.
    Loria P; Bertolotti M; Cassinadri MT; Dilengite MA; Bozzoli M; Carubbi F; Concari M; Guicciardi ME; Carulli N
    Hepatology; 1994 Apr; 19(4):882-8. PubMed ID: 8138261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ursocholic acid on bile lipid secretion and composition.
    Loria P; Carulli N; Medici G; Menozzi D; Salvioli G; Bertolotti M; Montanari M
    Gastroenterology; 1986 Apr; 90(4):865-74. PubMed ID: 3949116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H; Fager G
    Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin added to ursodeoxycholic acid does not enhance disappearance of gallstone fragments after shock wave therapy.
    Sackmann M; Koelbl R; Pauletzki J; Cremer P; Klueppelberg UG; von Ritter C; Sauter G; Holl J; Seidel D; Paumgartner G
    Z Gastroenterol; 1995 Oct; 33(10):585-9. PubMed ID: 7502550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lovastatin on biliary lipid secretion and bile acid metabolism in humans.
    Mitchell JC; Logan GM; Stone BG; Duane WC
    J Lipid Res; 1991 Jan; 32(1):71-8. PubMed ID: 2010695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Swiss simvastatin multicenter study: 1. Efficacy of 10 mg simvastatin daily in patients with primary hypercholesterolemia].
    Riesen WF; Keller U; Del Bufalo A; Reutter FW; Baur HR; Golay A; Bertel O; Kummer H; Kistler H; Ammann F
    Schweiz Med Wochenschr; 1989 Dec; 119(48):1719-23. PubMed ID: 2694363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.